BioLife Sciences Inc.
BLFE · OTC
2/28/2022 | 8/31/2021 | 5/31/2021 | 2/28/2021 | |
|---|---|---|---|---|
| Market Cap | $37 | $19 | $18 | $25 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $37 | $20 | $19 | $25 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.002 | -0.003 | -0.003 | -0.001 |
| % Growth | 11.5% | -4% | -108.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |